Past major depression and smoking cessation outcome

A systematic review and meta-analysis update

Brian Hitsman*, George D. Papandonatos, Dennis E. McChargue, Andrew Demott, María José Herrera, Bonnie Spring, Belinda Borrelli, Raymond Niaura

*Corresponding author for this work

Research output: Contribution to journalReview article

84 Citations (Scopus)

Abstract

Aims: To update our prior meta-analysis that showed past major depression (MD+) to be unrelated to smoking cessation outcome. Methods: Eligible trials included 14 from our original review and 28 identified through an updated systematic review (2000-2009). We coded for assessment of past MD, exclusion for recent MD episode (MDE; ≤6 months versus no exclusion), duration/modality of cognitive behavioral treatment (CBT; face-to-face versus self-help) and other factors. To minimize influence of experimental treatments that may selectively benefit MD+ smokers we analyzed placebo/lowest intensity control arms only. Study-specific ORs for the effect of past MD on short-term (≤3 months) and long-term (≥6 months) abstinence were estimated and combined using random effects. Two-way interaction models of past MD with study methodology and treatment factors were used to evaluate hypothesized moderators of the past MD-abstinence association. Results: MD+ smokers had 17% lower odds of short-term abstinence (n=35, OR=0.83, 95% CI=0.72-0.95, P=0.009) and 19% lower odds of long-term abstinence (n=38, OR=0.81, 95% CI=0.67-0.97, P=0.023) than MD- smokers after excluding the sole study of varenicline because of its antidepressant properties. The association between past MD and abstinence was affected by methodological (recent MDE exclusion, type of MD assessment) and treatment (CBT modality) factors. Conclusions: Past major depression has a modest adverse effect on abstinence during and after smoking cessation treatment. An increased focus on the identification of effective treatments or treatment adaptations that eliminate this disparity in smoking cessation for MD+ smokers is needed.

Original languageEnglish (US)
Pages (from-to)294-306
Number of pages13
JournalAddiction
Volume108
Issue number2
DOIs
StatePublished - Feb 1 2013

Fingerprint

Smoking Cessation
Meta-Analysis
Depression
Therapeutics
Withholding Treatment
Antidepressive Agents
Placebos

Keywords

  • Heterogeneity
  • Major depression
  • Meta-analysis
  • Smoking cessation
  • Systematic review
  • Treatment

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Psychiatry and Mental health

Cite this

Hitsman, B., Papandonatos, G. D., McChargue, D. E., Demott, A., Herrera, M. J., Spring, B., ... Niaura, R. (2013). Past major depression and smoking cessation outcome: A systematic review and meta-analysis update. Addiction, 108(2), 294-306. https://doi.org/10.1111/add.12009
Hitsman, Brian ; Papandonatos, George D. ; McChargue, Dennis E. ; Demott, Andrew ; Herrera, María José ; Spring, Bonnie ; Borrelli, Belinda ; Niaura, Raymond. / Past major depression and smoking cessation outcome : A systematic review and meta-analysis update. In: Addiction. 2013 ; Vol. 108, No. 2. pp. 294-306.
@article{b1b6cfd7071448dfa8b3a6778a21097c,
title = "Past major depression and smoking cessation outcome: A systematic review and meta-analysis update",
abstract = "Aims: To update our prior meta-analysis that showed past major depression (MD+) to be unrelated to smoking cessation outcome. Methods: Eligible trials included 14 from our original review and 28 identified through an updated systematic review (2000-2009). We coded for assessment of past MD, exclusion for recent MD episode (MDE; ≤6 months versus no exclusion), duration/modality of cognitive behavioral treatment (CBT; face-to-face versus self-help) and other factors. To minimize influence of experimental treatments that may selectively benefit MD+ smokers we analyzed placebo/lowest intensity control arms only. Study-specific ORs for the effect of past MD on short-term (≤3 months) and long-term (≥6 months) abstinence were estimated and combined using random effects. Two-way interaction models of past MD with study methodology and treatment factors were used to evaluate hypothesized moderators of the past MD-abstinence association. Results: MD+ smokers had 17{\%} lower odds of short-term abstinence (n=35, OR=0.83, 95{\%} CI=0.72-0.95, P=0.009) and 19{\%} lower odds of long-term abstinence (n=38, OR=0.81, 95{\%} CI=0.67-0.97, P=0.023) than MD- smokers after excluding the sole study of varenicline because of its antidepressant properties. The association between past MD and abstinence was affected by methodological (recent MDE exclusion, type of MD assessment) and treatment (CBT modality) factors. Conclusions: Past major depression has a modest adverse effect on abstinence during and after smoking cessation treatment. An increased focus on the identification of effective treatments or treatment adaptations that eliminate this disparity in smoking cessation for MD+ smokers is needed.",
keywords = "Heterogeneity, Major depression, Meta-analysis, Smoking cessation, Systematic review, Treatment",
author = "Brian Hitsman and Papandonatos, {George D.} and McChargue, {Dennis E.} and Andrew Demott and Herrera, {Mar{\'i}a Jos{\'e}} and Bonnie Spring and Belinda Borrelli and Raymond Niaura",
year = "2013",
month = "2",
day = "1",
doi = "10.1111/add.12009",
language = "English (US)",
volume = "108",
pages = "294--306",
journal = "Addiction",
issn = "0965-2140",
publisher = "Wiley-Blackwell",
number = "2",

}

Hitsman, B, Papandonatos, GD, McChargue, DE, Demott, A, Herrera, MJ, Spring, B, Borrelli, B & Niaura, R 2013, 'Past major depression and smoking cessation outcome: A systematic review and meta-analysis update', Addiction, vol. 108, no. 2, pp. 294-306. https://doi.org/10.1111/add.12009

Past major depression and smoking cessation outcome : A systematic review and meta-analysis update. / Hitsman, Brian; Papandonatos, George D.; McChargue, Dennis E.; Demott, Andrew; Herrera, María José; Spring, Bonnie; Borrelli, Belinda; Niaura, Raymond.

In: Addiction, Vol. 108, No. 2, 01.02.2013, p. 294-306.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Past major depression and smoking cessation outcome

T2 - A systematic review and meta-analysis update

AU - Hitsman, Brian

AU - Papandonatos, George D.

AU - McChargue, Dennis E.

AU - Demott, Andrew

AU - Herrera, María José

AU - Spring, Bonnie

AU - Borrelli, Belinda

AU - Niaura, Raymond

PY - 2013/2/1

Y1 - 2013/2/1

N2 - Aims: To update our prior meta-analysis that showed past major depression (MD+) to be unrelated to smoking cessation outcome. Methods: Eligible trials included 14 from our original review and 28 identified through an updated systematic review (2000-2009). We coded for assessment of past MD, exclusion for recent MD episode (MDE; ≤6 months versus no exclusion), duration/modality of cognitive behavioral treatment (CBT; face-to-face versus self-help) and other factors. To minimize influence of experimental treatments that may selectively benefit MD+ smokers we analyzed placebo/lowest intensity control arms only. Study-specific ORs for the effect of past MD on short-term (≤3 months) and long-term (≥6 months) abstinence were estimated and combined using random effects. Two-way interaction models of past MD with study methodology and treatment factors were used to evaluate hypothesized moderators of the past MD-abstinence association. Results: MD+ smokers had 17% lower odds of short-term abstinence (n=35, OR=0.83, 95% CI=0.72-0.95, P=0.009) and 19% lower odds of long-term abstinence (n=38, OR=0.81, 95% CI=0.67-0.97, P=0.023) than MD- smokers after excluding the sole study of varenicline because of its antidepressant properties. The association between past MD and abstinence was affected by methodological (recent MDE exclusion, type of MD assessment) and treatment (CBT modality) factors. Conclusions: Past major depression has a modest adverse effect on abstinence during and after smoking cessation treatment. An increased focus on the identification of effective treatments or treatment adaptations that eliminate this disparity in smoking cessation for MD+ smokers is needed.

AB - Aims: To update our prior meta-analysis that showed past major depression (MD+) to be unrelated to smoking cessation outcome. Methods: Eligible trials included 14 from our original review and 28 identified through an updated systematic review (2000-2009). We coded for assessment of past MD, exclusion for recent MD episode (MDE; ≤6 months versus no exclusion), duration/modality of cognitive behavioral treatment (CBT; face-to-face versus self-help) and other factors. To minimize influence of experimental treatments that may selectively benefit MD+ smokers we analyzed placebo/lowest intensity control arms only. Study-specific ORs for the effect of past MD on short-term (≤3 months) and long-term (≥6 months) abstinence were estimated and combined using random effects. Two-way interaction models of past MD with study methodology and treatment factors were used to evaluate hypothesized moderators of the past MD-abstinence association. Results: MD+ smokers had 17% lower odds of short-term abstinence (n=35, OR=0.83, 95% CI=0.72-0.95, P=0.009) and 19% lower odds of long-term abstinence (n=38, OR=0.81, 95% CI=0.67-0.97, P=0.023) than MD- smokers after excluding the sole study of varenicline because of its antidepressant properties. The association between past MD and abstinence was affected by methodological (recent MDE exclusion, type of MD assessment) and treatment (CBT modality) factors. Conclusions: Past major depression has a modest adverse effect on abstinence during and after smoking cessation treatment. An increased focus on the identification of effective treatments or treatment adaptations that eliminate this disparity in smoking cessation for MD+ smokers is needed.

KW - Heterogeneity

KW - Major depression

KW - Meta-analysis

KW - Smoking cessation

KW - Systematic review

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84872531313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872531313&partnerID=8YFLogxK

U2 - 10.1111/add.12009

DO - 10.1111/add.12009

M3 - Review article

VL - 108

SP - 294

EP - 306

JO - Addiction

JF - Addiction

SN - 0965-2140

IS - 2

ER -